Catalyst Wire Dossier Catalyst Wire Dossier

Tropocells Autologous Platelet-rich Fibrin (PRF)

platelet-rich fibrin · Estar Medical dba Medical Technologies, LTD
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tropocells Autologous Platelet-rich Fibrin (PRF), covering 2025-06-12 to 2025-06-12. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care. [Phase 2]

See pricing